Nu-Med Plus, Inc.
NUMD
$0.054
-$0.006-10.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -46.19% | -47.47% | 52.65% | -6.55% | -23.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -46.19% | -47.47% | 52.65% | -6.63% | -23.73% |
| Operating Income | 46.19% | 47.47% | -52.65% | 6.63% | 23.73% |
| Income Before Tax | 44.16% | 45.50% | -334.98% | -64.85% | -16.99% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 44.16% | 45.50% | -334.98% | -64.85% | -16.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 44.16% | 45.50% | -334.98% | -64.85% | -16.99% |
| EBIT | 46.19% | 47.47% | -52.65% | 6.63% | 23.73% |
| EBITDA | -- | -- | 21.60% | 38.75% | 38.20% |
| EPS Basic | 53.33% | 46.67% | -366.67% | -75.00% | -25.00% |
| Normalized Basic EPS | 55.56% | 44.44% | -33.33% | 20.00% | 30.77% |
| EPS Diluted | 53.33% | 46.67% | -366.67% | -75.00% | -25.00% |
| Normalized Diluted EPS | 55.56% | 44.44% | -33.33% | 20.00% | 30.77% |
| Average Basic Shares Outstanding | 2.28% | 2.97% | 1.07% | 1.57% | 2.20% |
| Average Diluted Shares Outstanding | 2.28% | 2.97% | 1.07% | 1.57% | 2.20% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |